Orion Portfolio Solutions LLC Sells 865 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Orion Portfolio Solutions LLC decreased its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 26.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,395 shares of the company’s stock after selling 865 shares during the quarter. Orion Portfolio Solutions LLC’s holdings in HealthEquity were worth $230,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in HQY. Pier Capital LLC purchased a new position in HealthEquity during the 4th quarter valued at about $8,024,000. HighTower Advisors LLC increased its holdings in HealthEquity by 4.8% during the fourth quarter. HighTower Advisors LLC now owns 95,075 shares of the company’s stock valued at $9,122,000 after buying an additional 4,370 shares during the period. Geneva Capital Management LLC raised its stake in HealthEquity by 24.6% in the fourth quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company’s stock worth $100,642,000 after buying an additional 206,894 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in HealthEquity by 2.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,086,811 shares of the company’s stock worth $104,280,000 after buying an additional 25,004 shares during the period. Finally, Venturi Wealth Management LLC bought a new stake in HealthEquity during the 4th quarter valued at $238,000. 99.55% of the stock is currently owned by institutional investors.

Insider Activity at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the sale, the director now owns 78,219 shares in the company, valued at $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Michael Henry Fiore sold 8,881 shares of the firm’s stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the transaction, the executive vice president now directly owns 56,655 shares of the company’s stock, valued at $4,433,820.30. This represents a 13.55 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.20% of the stock is owned by insiders.

HealthEquity Trading Down 3.8 %

NASDAQ HQY opened at $79.94 on Friday. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $115.59. The company has a fifty day simple moving average of $98.22 and a two-hundred day simple moving average of $96.27. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The stock has a market cap of $6.91 billion, a P/E ratio of 73.34, a P/E/G ratio of 1.60 and a beta of 0.49.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on HQY shares. Raymond James raised HealthEquity from an “outperform” rating to a “strong-buy” rating and reduced their price target for the stock from $120.00 to $115.00 in a research report on Tuesday, March 25th. Barrington Research reiterated an “outperform” rating and issued a $112.00 target price on shares of HealthEquity in a report on Friday, March 14th. The Goldman Sachs Group lowered their price target on shares of HealthEquity from $107.00 to $94.00 and set a “neutral” rating on the stock in a report on Thursday, March 27th. KeyCorp cut their price objective on shares of HealthEquity from $120.00 to $110.00 and set an “overweight” rating on the stock in a research report on Monday, March 24th. Finally, Wells Fargo & Company increased their target price on shares of HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research report on Wednesday, February 26th. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, HealthEquity currently has an average rating of “Buy” and an average target price of $112.58.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.